Thanks Ma420. Its a great interview, and AT expands on the additional pre-clinical work that looks at other indications beyond prostate cancer.
Clearly Clarity is developing a substantial platform that into the future will be huge. I can see the Company, if it were to survive as a separate entity, to be a leader in cancer diagnostics and therapy over a broader spectrum than the current market can possibly value.
It really is an exciting pioneer in the radiopharma space and AT is an impressive leader.
- Forums
- ASX - By Stock
- CU6 - Media and Industry News
Thanks Ma420. Its a great interview, and AT expands on the...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.59 |
Change
-0.110(1.26%) |
Mkt cap ! $2.756B |
Open | High | Low | Value | Volume |
$8.65 | $8.79 | $8.50 | $4.226M | 490.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 2440 | $8.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.60 | 2915 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 3119 | 8.550 |
5 | 2733 | 8.540 |
4 | 2610 | 8.530 |
4 | 1643 | 8.520 |
5 | 3853 | 8.510 |
Price($) | Vol. | No. |
---|---|---|
8.570 | 4260 | 15 |
8.580 | 4266 | 8 |
8.590 | 5693 | 12 |
8.600 | 7720 | 10 |
8.610 | 1515 | 4 |
Last trade - 12.24pm 27/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |